Literature DB >> 4699685

Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma.

J R Kent, A J Bischoff, L J Arduino, G T Mellinger, D P Byar, M Hill, X Kozbur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4699685     DOI： 10.1016/s0022-5347(17)60564-0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolactin.

Authors:  G H Jacobi; K Sinterhauf; K H Kurth; J E Altwein
Journal:  Urol Res       Date:  1978

2.  Effective testosterone suppression for prostate cancer: is there a best castration therapy?

Authors:  Leonard G Gomella
Journal:  Rev Urol       Date:  2009

3.  Gestagens in the management of prostatic carcinoma.

Authors:  Z Szendröi
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

Review 4.  Hormonal Therapy for Prostate Cancer.

Authors:  Kunal Desai; Jeffrey M McManus; Nima Sharifi
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.